🔎 Trials Near Me

홈 › 급성 골수성 백혈병 › 뉴욕 › New York City

NY New York City의 급성 골수성 백혈병 임상 시험

급성 골수성 백혈병 관련 연구 51개가 New York City 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.

공식 연구 텍스트(영어)

연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →

MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Within myeloMATCH (MyeloMATCH Screening Trial)

피험자 모집 중2상
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT05564390

A Study to Find the Highest Dose of Cedazuridine and Decitabine Combination With Filgrastim as a Treatment Option After Hematopoietic Stem Cell Transplant in Children With High-Risk Acute Myeloid Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
21세 이하 · 모든 성별 · 2026. 10. 5. 업데이트됨 · NCT07012044

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

피험자 모집 중관찰 연구건강한 지원자 환영
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
40세 ~ 75세 · 모든 성별 · 2026. 10. 2. 업데이트됨 · NCT05334069

Testing the Anti-cancer Drug, Cirtuvivint, and Its Combination With ASTX727 to Improve Outcomes in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndromes

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 10. 1. 업데이트됨 · NCT06484062

A Phase 1 Study of Orca-Q in Recipients Undergoing Allogeneic Transplantation for Hematologic Malignancies

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
12세 ~ 78세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT03802695

Comparing Cytarabine + Daunorubicin Therapy Versus Cytarabine + Daunorubicin + Venetoclax Versus Venetoclax + Azacitidine in Younger Patients With Intermediate Risk AML (A MyeloMATCH Treatment Trial)

피험자 모집 중2상
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 ~ 59세 · 모든 성별 · 2026. 9. 28. 업데이트됨 · NCT05554393

A Study of Bleximenib, Venetoclax and Azacitidine For Treatment of Participants With Newly Diagnosed Acute Myeloid Leukemia (AML)

피험자 모집 중3상
  • Memorial Sloan Kettering Cancer Center, New York
  • New York Presbyterian - Weill Cornell, New York
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06852222

Comparing New Treatments for People With Newly Diagnosed Acute Myeloid Leukemia That Has an IDH2 Gene Change (A MyeloMATCH Treatment Trial)

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06672146

Testing New Therapies for Patients With Acute Myeloid Leukemia Who Are Newly Diagnosed and Have Not Yet Started Treatment (A MyeloMATCH Treatment Trial)

피험자 모집 중2상
  • Mount Sinai Hospital, New York
  • Memorial Sloan Kettering Cancer Center, New York
18세 ~ 59세 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT05554406

A Study of CRD3874-SI in People With Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07661095

Venetoclax and HMA Treatment of Older and Unfit Adults With FLT3 Mutated Acute Myeloid Leukemia (AML) (A MyeloMATCH Treatment Trial)

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT06317649

A Multi-Site Break Through Cancer Trial: Phase II Study Investigating Dual Inhibition of BCL2 and Menin in AML MRD Using the Combination of Venetoclax and Revumenib

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center, New York
12세 이상 · 모든 성별 · 2026. 9. 18. 업데이트됨 · NCT06284486

A Study to Compare Standard Chemotherapy to Therapy With CPX-351 and/or Gilteritinib for Patients With Newly Diagnosed AML With or Without FLT3 Mutations

피험자 모집 중3상
  • Laura and Isaac Perlmutter Cancer Center at NYU Langone, New York
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • 외 1개
6 Months – 21 Years · 모든 성별 · 2026. 9. 17. 업데이트됨 · NCT04293562

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

피험자 모집 중1/2상
  • Montefiore Medical Center, New York
30 Days · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT04065399

Evaluation of Two Dose Levels of Quizartinib as Maintenance in FLT3-ITD (+) Acute Myeloid Leukemia Patients in Complete Remission

피험자 모집 중2상
  • Weill Cornell, New York
18세 이상 · 모든 성별 · 2026. 9. 16. 업데이트됨 · NCT06824168

Cord Blood Transplant in Adults With Blood Cancers

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
21세 ~ 65세 · 모든 성별 · 2026. 9. 11. 업데이트됨 · NCT05884333

Eganelisib as Monotherapy and in Combination With Cytarabine in Relapsed/Refractory AML

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
  • Montefiore Medical Center, New York
18세 이상 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT06533761

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

피험자 모집 중1/2상
  • NYP/Columbia University Medical Center/Herbert Irving Comprehensive Cancer Center, New York
  • Memorial Sloan Kettering Cancer Center, New York
22세 이하 · 모든 성별 · 2026. 8. 25. 업데이트됨 · NCT04726241

Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)

피험자 모집 중3상
  • Columbia University Irving Medical Center, New York
  • Memorial Sloan Kettering Cancer Center - New York, New York
29 Days – 21 Years · 모든 성별 · 2026. 8. 24. 업데이트됨 · NCT05183035

Studies to Assess Ziftomenib in Combination With Ven+Aza or 7+3 in Patients With Untreated NPM1-m or KMT2A-r AML

피험자 모집 중3상
  • Icahn School of Medicine at Mount Sinai, New York
  • Columbia University, New York
  • Weill Cornell Medical Center, New York
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT07007312

Safety and Tolerability of Ziftomenib Combinations in Patients With Relapsed/Refractory Acute Myeloid Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
  • Weill Cornell Medical College-NY Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2026. 8. 20. 업데이트됨 · NCT06001788

ICP-248 in Combination With Azacitidine for the Treatment in Patients With Myeloid Malignancies

피험자 모집 중1상
  • NYU Langone Health, New York
18세 이상 · 모든 성별 · 2026. 8. 18. 업데이트됨 · NCT06656494

Olutasidenib DDI Study in Patients With IDH1 Mutation Positive Malignancies

피험자 모집 중4상
  • New York Presbyterian Hospital-Columbia University Medical Center, New York
18세 이상 · 모든 성별 · 2026. 8. 11. 업데이트됨 · NCT07486713

Study of Revumenib, Azacitidine, and Venetoclax in Pediatric and Young Adult Patients With Refractory or Relapsed Acute Myeloid Leukemia

피험자 모집 중1상
  • Memorial Sloan- Kettering Cancer Center, New York
1세 ~ 30세 · 모든 성별 · 2026. 8. 3. 업데이트됨 · NCT06177067

Study of AZD3632 Monotherapy or in Combination With Anticancer Agents in Participants With Advanced Haematologic Malignancies With KMT2Ar, NPM1m, or Other Genotypes Associated With HOX Overexpression

피험자 모집 중1/2상
  • Research Site, New York
16세 이상 · 모든 성별 · 2026. 7. 20. 업데이트됨 · NCT07155226

A Study of the Combination of Ivosidenib, Azacitidine, and Venetoclax Followed by Ivosidenib Alone in People With Acute Myeloid Leukemia

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
60세 이상 · 모든 성별 · 2026. 7. 17. 업데이트됨 · NCT07392242

Trial of Orca-T Following Reduced Intensity or Nonmyeloablative Conditioning in Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome

피험자 모집 중2상
  • Weill Cornell Medicine - New York Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2026. 7. 7. 업데이트됨 · NCT07216443

A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)

피험자 모집 중관찰 연구
  • New York University Langone Medical Center, New York
  • New York Presbyterian Hospital at Cornell, New York
  • Mount Sinai Medical Center - New York, New York
  • 외 3개
전 연령 · 모든 성별 · 2026. 7. 6. 업데이트됨 · NCT01351545

A Study of Revumenib and Mezigdomide in People With Leukemia

피험자 모집 중1/2상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
12세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT07356154

A Study of CD371-YSNVZIL-18 CAR T Cells in People With Acute Myeloid Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All protocol activites), New York
1세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT06017258

A Study of Gilteritinib in Combination With Ivosidenib or Enasidenib in People With Acute Myeloid Leukemia (AML)

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 6. 22. 업데이트됨 · NCT05756777

A Study of Natural Killer Cells in Combination With Atezolizumab in People With Acute Myelogenous Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 ~ 70세 · 모든 성별 · 2026. 6. 17. 업데이트됨 · NCT07011004

BAL0891 in Patients With Advanced Solid Tumors or Relapsed or Refractory Acute Myeloid Leukemia

피험자 모집 중1상
  • New York Medicine-New York-Presbyterian Hospital, New York
  • Montefiore Medical Center - Montefiore Hospital, New York
18세 이상 · 모든 성별 · 2026. 6. 15. 업데이트됨 · NCT05768932

Cord Blood Transplantation in Children and Young Adults With Blood Cancer

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
26세 이하 · 모든 성별 · 2026. 5. 14. 업데이트됨 · NCT07566377

A Multi-phase Study of ASTX030 (Azacitidine and Cedazuridine) in Myeloid Neoplasm Alone or in Combination With Venetoclax in AML (AZTOUND Study)

피험자 모집 중2/3상
  • Perlmutter Cancer Center - 34th Street, New York
  • Icahn School of Medicine at Mount Sinai, New York
18세 이상 · 모든 성별 · 2026. 4. 30. 업데이트됨 · NCT04256317

Imetelstat Combinations in Relapsed AML

피험자 모집 중1상
  • Icahn School of Medicine at Mount Sinai, New York
18세 이상 · 모든 성별 · 2026. 4. 22. 업데이트됨 · NCT07320235

A Study of GLB-001 in Patients With Relapsed or Refractory Acute Myeloid Leukemia or Relapsed or Refractory Higher Risk Myelodysplastic Syndromes

피험자 모집 중1상
  • Icahn School of Medicine at Mount Sinai, New York
18세 이상 · 모든 성별 · 2026. 4. 13. 업데이트됨 · NCT06146257

Safety and Proof-of-Concept Study of RPT1G in Adults With Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndromes

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 3. 25. 업데이트됨 · NCT07107126

A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation

피험자 모집 중2상
  • Memorial Sloan Kettering, New York
18세 ~ 66세 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06859424

A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
12세 이상 · 모든 성별 · 2026. 3. 16. 업데이트됨 · NCT06994676

A Study to Investigate the Safety and Tolerability of Ziftomenib in Combination With Venetoclax/Azacitidine, Venetoclax, 7+3, or 7+3+Quizartinib in Patients With AML

피험자 모집 중1상
  • New York - Presbyterian / Weill Cornell Medicine, New York
  • Mount Sinai - Ruttenberg Treatment Center, New York
  • Columbia University Medical Center, New York
18세 이상 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT05735184

Cord Blood Transplant in Children and Young Adults With Blood Cancers and Non-malignant Disorders

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center, New York
21세 이하 · 모든 성별 · 2026. 3. 13. 업데이트됨 · NCT04644016

A Study of ADCLEC.syn1 in People With Acute Myeloid Leukemia

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2026. 3. 10. 업데이트됨 · NCT05748197

A Study of Azacitidine and Venetoclax in People With Acute Myeloid Leukemia (AML)

피험자 모집 중2상
  • Memorial Sloan Kettering Cancer Center (All Protocol Activities), New York
18세 이상 · 모든 성별 · 2026. 2. 24. 업데이트됨 · NCT06773208

CLN-049 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML) or Myelodysplastic Syndrome (MDS)

피험자 모집 중1상
  • New York University, New York
18세 이상 · 모든 성별 · 2026. 1. 16. 업데이트됨 · NCT05143996

Pharmacokinetic and Safety Study of MRX-2843 in Adolescents and Adults With Relapsed/Refractory AML, ALL, or MPAL

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
12세 이상 · 모든 성별 · 2026. 1. 8. 업데이트됨 · NCT04872478

A Study of BH-30236 in Relapsed/ Refractory Acute Myelogenous Leukemia and Higher Risk Myelodysplastic Syndrome

피험자 모집 중1상
  • Memorial Sloan Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2025. 9. 24. 업데이트됨 · NCT06501196

Study of REM-422 in Patients With AML or Higher Risk MDS

피험자 모집 중1상
  • Memorial Sloan Kettering, New York
18세 이상 · 모든 성별 · 2025. 4. 23. 업데이트됨 · NCT06297941

A Clinical Trial of BP1002 in Patients With Refractory/Relapsed Acute Myeloid Leukemia (AML)

피험자 모집 중1상
  • Weill Cornell Medical College - NewYork-Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2025. 3. 10. 업데이트됨 · NCT05190471

Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML

피험자 모집 중2상
  • Laura & Isaac Pe lmutter Cancer Center at NYU Langone Health, New York
  • Weill Cornell Medical College - New York - Presbyterian Hospital, New York
18세 이상 · 모든 성별 · 2025. 3. 7. 업데이트됨 · NCT02781883

A Study of BTX-A51 in People With Relapsed or Refractory Acute Myeloid Leukemia or High-Risk Myelodysplastic Syndrome

피험자 모집 중1상
  • Memorial Sloan-Kettering Cancer Center, New York
18세 이상 · 모든 성별 · 2024. 3. 20. 업데이트됨 · NCT04243785

다른 도시의 급성 골수성 백혈병 시험

New York City의 다른 연구

ClinicalTrials.gov 출처, 2026. 10. 6. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.